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Alternative splice-site selection is regulated by the relative con-
centration of individual members of the serine-arginine family of
proteins and heterogeneous nuclear ribonucleoproteins. Most
of these proteins accumulate predominantly in the nucleus, and
a subset of them shuttles continuously between nucleus and
cytosol. We demonstrate that in primary neuronal cultures, a
rise in intracellular calcium concentration induced by thapsigar-
gin leads to a translocation of the splicing regulatory protein
tra2-1 and a consequent change in splice-site selection. To
investigate this phenomenon under physiological conditions,
we used an ischemia model. Ischemia induced in the brain
causes a cytoplasmic accumulation and hyperphosphorylation
of tra2-1. In addition, several of the proteins binding to tra2-
1, such as src associated in mitosis 68 and serine/arginine-
rich proteins, accumulate in the cytosol. Concomitant with this
subcellular relocalization, we observed a change in alternative
splice-site usage of the ICH-1 gene. The increased usage of its
alternative exons is in agreement with previous studies dem-
onstrating its repression by a high concentration of proteins
with serine/arginine-rich domains. Our findings suggest that a
change in the calcium concentration associated with ischemia
is part of a signaling event, which changes pre-mRNA splicing
pathways by causing relocalization of proteins that regulate
splice-site selection.
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Advances in the human genome project have shown that almost
all human genes contain introns that are removed during pre-
mRNA processing. An estimated 47–60% of genes contain exons
that can be used alternatively (Lander et al., 2001; Modrek et al.,
2001). Alternative pre-mRNA processing plays a key role in
generating a vast proteome of 150,000–1,000,000 proteins from
the surprisingly low number of 30,000–40,000 genes (Lander et
al., 2001; Hodges et al., 2002). Alternative splicing pathways can
be regulated (e.g., during development) in response to cellular
activity, in response to stress, during programmed cell death, or
as a result of a pathological state (Daoud et al., 2000; Stoss et al.,
2000; Akker et al., 2001; Grabowski and Black, 2001; Soreq and
Seidman, 2001).
Current models indicate that a fine-tuned balance of cis-
elements and trans-acting factors is responsible for proper alter-
native splice-site selection (Grabowski, 1998; Elliot, 2000; Smith
and Valcarcel, 2000). The major cis-elements comprise 5 and 3
splice sites and auxiliary sequence elements near them that act as
enhancers or silencers. Those auxiliary elements bind to two
major groups of proteins, proteins with serine-arginine-rich
domains (SR proteins) (Fu, 1995; Manley and Tacke, 1996;
Graveley, 2000) and heterogeneous nuclear ribonucleoproteins
(hnRNPs) (Weighardt et al., 1996), which can change the recog-
nition of splice sites because both SR proteins and hnRNPs bind
to components of the spliceosome (Tian and Maniatis, 1993;
Hertel et al., 1997; Liu et al., 1998, 2000; Chew et al., 1999). As a
result, alternative exons can be regulated by modulation of the
concentration of SR proteins and hnRNPs (Ca´ceres et al., 1994;
Wang and Manley, 1995; Manley and Tacke, 1996) that have a
characteristic concentration in a given tissue (Kamma et al., 1995;
Hanamura et al., 1998).
Stroke is a leading cause of morbidity and mortality in indus-
trialized countries, imposing an enormous economic burden on
the families of the patients and the society overall (Taylor et al.,
1996). The trigger of stroke is a focal reduction of blood flow
below the threshold required to maintain oxidative respiration
(Hossmann, 1994). However, in the vicinity of this primary ne-
crotic lesion, secondary disturbances evolve and gradually expand
and produce additional injury, the amount of which may outweigh
that of the primary impact (Heiss et al., 1994; Gyngell et al.,
1995). The reasons for this delayed ischemic injury are only partly
understood. Gene expression analysis suggests that 1000 genes
are either upregulated or downregulated by more than a factor of
four, and that many of these may be directly involved in the injury
propagation (Trendelenburg et al., 2000). This integrated pattern
of genomic dysregulation would also be complicated by mis-
splicing or alternative splicing; however, until now, this question
has not been addressed.
We demonstrate that as a reaction to stroke, nuclear proteins
regulating pre-mRNA splicing change their subcellular distribu-
tion and accumulate in the cytosol. Concomitantly, alternative
splice-site selection of the ICH-1 gene is changed, suggesting that
a change in alternative splicing patterns contributes to the out-
come of stroke.
MATERIAL AND METHODS
Primary neuron cultures. Cortex regions were dissected from embryonic
day 19 rats. The tissue was digested for 20 min with 500 g of papain
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(Sigma, St. Louis, MO) in the presence of 10 mM glucose, 1 mg/ml
bovine serum albumin, and 10 g DNase in PBS. The cells were carefully
dissociated with a pipette, and the mixture was centrifuged at 1000  g
for 5 min. The cells were resuspended in DMEM containing 15% fetal
calf serum and were plated onto poly-DL-ornithine-precoated six well
dishes (Nunc, Naperville, IL). The density of plating was 1  10 6 cells/
well. Approximately 1 hr after plating, the medium was changed to a
serum-free complete medium (Stamm et al., 1993) and the cells were
cultured at 37°C in a 10% CO2 humidified atmosphere. After 1 week, cells
were subjected to treatment with thapsigargin (1 M) (Sigma) for 1–24 hr.
Immunostaining. For immunohistochemistry, C57BL/6 mice were sub-
jected to transient focal cerebral ischemia for 1 hr and the animals were
immediately frozen in situ in liquid nitrogen at various recirculation
times. Brains were then removed in a cold temperature cabinet at20°C.
Coronal cryostat sections were cut at 20 m, placed on gelatinized slides,
and stored at20°C. Sections were fixed in 4% paraformaldehyde in PBS
for 30 min and were washed three times in PBS. They were preincubated
for 1 hr in 3% NGS with 0.5% Triton X-100 in PBS at room temperature
and were then incubated overnight at 4°C with the tra2-1 antiserum
(1:500), anti-monoclonal antibody (mAb)104 (1:1) (American Type Cul-
ture Collection, Manassas, VA), anti-src associated in mitosis (SAM)68
(Santa Cruz Biotechnology, Santa Cruz, CA) (1:50), anti-rat SAM68-like
molecule-2 (rSLM-2) (1:100) (Stoss et al., 2001), and anti-cleaved
caspase-3 (New England Biolabs, Beverly, MA) in PBS containing 0.3%
NGS and 0.5% Triton X-100. After three washes in PBS, the sections
were incubated with the secondary Cy3-fluorochrome-conjugated goat
anti-rabbit or IgG mouse antibody (Jackson ImmunoResearch, West
Grove, PA). For anti-mAb104, we used the Cy3 anti-mouse IgM antibody
at a dilution of 1:200 in PBS for 2 hr. Next, the sections were counter-
stained with 0.5 g/ml 4,6-diamidino-2-phenylindole (DAPI; Sigma,
Deisenhofen, Germany) in PBS for 10 min or with 1:200 of the nuclear
Nissl counterstain (Neuro Trace Green Fluorescent Nissl Stain; Molec-
ular Probes; Leiden, The Netherlands), washed again three times with
PBS, and coverslipped with Gel-Mount (Biomeda Corporation, Frank-
furt, Germany).
Immunofluorescence images were obtained using confocal laser mi-
croscopy. The general overview of one section was obtained by scanning
the entire section with a CCD camera (Leica, Nussloch, Germany) and a
scanner integrated to the microscope. The quantification of the tra2-
positive cells was performed by Neurolucida (Leica).
Reverse transcription-PCR. Total RNA was extracted from the striatal
region of mice by the guanidinium thiocyanate method, as described
previously (Chomczynski and Sacchi, 1987). For reverse transcription
(RT)-PCR, cDNA was made from 1 g of total RNA using H-Moloney
murine leukemia virus reverse transcriptase (Invitrogen, San Diego,
CA), 5 mM random primers (Promega, Madison, WI), 0.1 mM deoxyN-
TPs, 10 U of RNasin, and 10 mM dithiothreitol. The reactions were
performed using the following primers: ICHrev, AATTCAAGG-
GACGGGTCATG; ICHfor, ATGCTAACTGTCCAAGTCTA.
The PCR conditions used were denaturation at 94°C for 2 min. Forty
cycles of denaturation (94°C for 30 sec), annealing (55°C for 30 sec), and
elongation (72°C for 30 sec) were then performed.
The final elongation was performed at 72°C for 10 min. PCR products
were resolved on 2% agarose gels and were quantified with the enhanced
analysis system of Herolab (Wiesloch, Germany).
Experimental groups. Experimental procedures were conducted with
governmental approval according to the National Institutes of Health
guidelines for the care and use of laboratory animals. Adult male
C57BL/6 mice weighing 20–28 gm were subjected to transient focal
ischemia by middle cerebral artery (MCA) occlusion for 1 hr without
reperfusion or with recirculation for 3, 6, and 24 hr (n  3–4 animals per
group).
Animal surgery. Animals were anesthetized with 1% halothane (30%
O2, remainder N2O). Rectal temperature was maintained between 36.5
and 37.0°C using a feedback-controlled heating system. During the
experiments, cortical blood flow was measured by laser Doppler flow-
metry (LDF) using a 1 mm fiberoptic probe (Perimed, Stockholm,
Sweden) positioned on the intact skull over the MCA territory to monitor
LDF changes during ischemia and after the onset of reperfusion. Focal
cerebral ischemia was induced using an intraluminal filament technique
(Hata et al., 1998). Briefly, a midline neck incision was made and the left
common and external carotid arteries were isolated and ligated. A
microvascular clip (FE691; Aesculap, Tuttlingen, Germany) was tempo-
rarily placed on the internal carotid artery. An 8-0 nylon monofilament
(Ethilon; Ethicon, Norderstedt, Germany) coated with silicon resin (Xan-
topren; Bayer Dental, Osaka, Japan) was introduced through a small
incision into the common carotid artery and was advanced 9 mm distal to
the carotid bifurcation for occlusion of the MCA. The size of the thread
(150–200 m) was matched to the body weight to ensure reproducible
vascular occlusion (Hata et al., 1998). After 60 min, reperfusion was
initiated by withdrawal of the thread. Twenty minutes later, anesthesia
was discontinued and animals were placed into their home cages. Ex-
periments were terminated under halothane anesthesia by in situ freezing
of animals. Tissue was stored at 80°C until additional processing.
Regional measurement of ATP. Brains were removed in a cold temper-
ature cabinet (20°C) and cut into 20-m-thick cryostat sections. Coro-
nal sections from the striatal level were mounted on coverslips for ATP
bioluminescent imaging and on gelatin-coated slides for immunohisto-
chemistry. For regional ATP measurement, coverslip-mounted in situ
frozen sections were freeze-dried and coated with a layer of frozen
reaction mix containing the enzymes, coenzymes, and cofactors neces-
sary for evoking ATP-specific bioluminescence (Kogure and Alonso,
1978). The tissue/enzyme bilayer was thawed, and light emission was
recorded with a cooled CCD camera (SensiCam) using the PC software
SensiControl (PCO CCD Imaging, Kelheim, Germany).
Western blot. Proteins for immunoblotting were prepared from the stri-
atal region of control and ischemic hemispheres by homogenizing 0.25 gm
of tissue in 1 ml of sample buffer (60 mM Tris/HCl, pH 6.8, 2% SDS, 0.1 M
dithiothreitol). Boiling and centrifugation were then performed.
Protein (30 g) was subjected to SDS-PAGE (12%), as described
previously (Laemmli, 1970), transferred onto ECL membranes (Amer-
sham Biosciences, Arlington Heights, IL), incubated with rabbit tra2
antiserum (Daoud et al., 1999), diluted 1:2000 in 1 NET (150 mM
NaCl, 5 mM EDTA, 50 mM Tris, pH 7.5, 0.05% Triton X-100, and 0.25%
gelatine)/2.5 gelatin, and detected with an anti-rabbit antiserum cou-
pled to horseradish peroxidase (Amersham Biosciences) (1:3000).
RESULTS
Blocking the sarco-endoplasmatic reticulum Ca2-
ATPases alters the subcellular localization of the
splicing regulatory protein tra2-1 in primary neurons
Previous studies have shown that an induction of the mitogen-
activated protein kinase kinase, 38 kDa (MKK-p38) pathway
causes a cytoplasmatic accumulation of the splicing regulatory
proteins hnRNP A1 and splicing factor 2 (SF2)/alternative splic-
ing factor (ASF) (van der Houven van Oordt et al., 2000). We
previously reported a change in splicing patterns after neuronal
stimulation (Daoud et al., 1999) and wanted to investigate
whether the splicing regulatory protein tra2-1 changes its intra-
cellular localization when intracellular calcium levels are ele-
vated. An increase in intracellular calcium was evoked in primary
neuronal cultures by blocking the sarco-endoplasmatic reticulum
Ca 2-ATPases with thapsigargin (Treiman et al., 1998). As
shown in Figure 1, thapsigargin treatment causes a change in the
subcellular localization of endogenous tra2-1 after 1 hr in pri-
mary rat cortical cultures. After 6 hr, tra2-1 immunoreactivity
can no longer be detected in the majority of nuclei (Fig. 1, 6 hr),
whereas application of the solvent (DMSO) had no effect. In
thapsigargin-treated cells, it could clearly be seen that tra2-1
immunoreactivity was detectable in the neurites. Similar results
were obtained when SR proteins were detected with the pan-
anti-SR antibody mAb104 (data not shown). Previous work dem-
onstrated that activation of MKK-p38 can cause a relocalization
of splicing factors. However, we were not able to detect phosphor-
ylation of MKK-p38, which would be indicative for the activation
of the MKK-p38 kinase pathway (data not shown).
We conclude that a change in the intracellular Ca2 concen-
tration, evoked by thapsigargin, causes an accumulation of
tra2-1 and SR proteins in the cytosol of primary neurons.
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Thapsigargin treatment changes the alternative
splicing patterns of ICH-1 in primary neuronal cultures
Next, we tested whether the thapsigargin-induced relocation of
splicing factors changes alternative splicing patterns. Cells were
treated with thapsigargin for 1–24 hr, and the splicing patterns of
the endogenous ICH-1 gene were determined. As shown in Figure
2, we observed an approximately fourfold increase in the ICH-1S
form. These data indicate that a change in intracellular calcium
evoked by thapsigargin can affect pre-mRNA processing pathways.
The number of tra2-1-positive nuclei decrease in an
ischemic focus
Calcium release from intracellular stores is the major cause for
calcium-related neuronal injury during cerebral ischemia (Pas-
chen et al., 1996; Grondahl et al., 1998). We therefore asked
whether a translocation of splicing factors is also observed under
such pathological conditions and applied an established ischemia
paradigm (Hara et al., 1996; Hata et al., 1998). In this model, mice
were subjected to 60 min of suture occlusion of the MCA and then
recirculation for 0, 3, 6, and 24 hr. The immediate pathophysio-
logical response of this treatment was a focal depletion of ATP
that defines the ischemic focus. To localize the ischemic focus,
tissue sections were analyzed with ATP-specific bioluminescence
(Kogure and Alonso, 1978). As expected, ATP was depleted in
the striatum at the end of 1 hr of MCA occlusion, but recircula-
tion resulted in the return of ATP 3 hr after ischemia. After 24 hr
of recirculation, a focus of secondary ATP depletion developed in
Figure 1. Intracellular localization of tra2-1 in primary neuronal cultures after treatment with thapsigargin. Primary cortical neurons were subjected
to treatment with thapsigargin. The intracellular localization of tra2-1 was determined by immunocytochemistry. The control (con) shows cells that
were treated with DMSO only for 3 hr. Other time points looked similar. Left column, tra2-1 is detected with a tra2-1 antiserum. Middle column, DAPI
staining of the same field. Right column, Overlay of the tra2-1 and DAPI staining. The numbers on the lef t indicate the time of thapsigargin treatment.
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the center of the MCA territory (Fig. 3A). We analyzed the
expression of a critical splicing regulatory protein, human tra2-1
(Beil et al., 1997), after the ischemic insult. Immunohistochem-
istry with an antiserum specific for tra2- revealed an altered
staining pattern in the ischemic focus after 6 and 24 hr of
recirculation. In particular, we noticed a decrease in the number
of tra2-1-positive nuclei (Fig. 3B; see Fig. 5 for larger magnifi-
cation). The presence and integrity of the nuclei were confirmed
by DAPI (Fig. 3C) and Nissl (see Fig. 5E) staining that also
allowed us to quantify the tra2--positive nuclei. We determined
the fraction of nuclei that were positive for tra2-1 by comparing
tra2-1 immunoreactivity with the nuclear DAPI staining, both in
the ischemic side and in the contralateral control side (Fig. 3D).
As expected, only 70% of the cells in the brain expressed
tra2-1, which is in agreement with our previous findings (Daoud
et al., 1999). After 1 hr of transient ischemia, this fraction
dropped to 50 and 40% after 6 and 24 hr of recirculation,
respectively. In contrast, no change in the amount of tra2-1-
positive nuclei was observed in the unaffected contralateral side
and in cortical regions distant to the territory supported by the
MCA. In contrast, the ischemic focus was not visible when the
sections were stained for rSLM-2 (Stoss et al., 2001) (data not
shown) (see Fig. 6C).
We conclude that after transient focal cerebral ischemia, the
number of tra2-1-positive nuclei decreases in the cells located in
the ischemic focus.
Ischemia causes hyperphosphorylation of tra2-1 and
a change in its subcellular distribution
Similar to other SR proteins, tra2-1 exists in different phosphor-
ylated forms that can be distinguished by PAGE. We investigated
whether ischemia alters the phosphorylation pattern (Daoud et
al., 1999). Using the ATP depletion as a marker for the ischemic
focus, we isolated tissue from the ischemic focus and the con-
tralateral control side from adjacent sections and analyzed pro-
tein extracts by Western blot using an antiserum against tra2-1.
As demonstrated previously, the antiserum detects two forms, a
slow-migrating hyperphosphorylated form and a fast-migrating
hypophosphorylated form (Daoud et al., 1999). The ischemic
insult leads to an increase in the hyperphosphorylated form after
6 and 24 hr (Fig. 4). In addition, no change in the total tra2-1
level was observed when the tra2-1 signal was compared with
actin and histone signals (data not shown).
We then stained the tissues with an antiserum against tra2-1
and inspected the cells of the ischemic focus under higher mag-
nification. Similar to the situation with primary neuronal culture,
we found that with the ischemic focus, tra2-1 immunoreactivity
decreased in the cell nuclei, whereas immunoreactivity became
detectable in the cytoplasma and the neurites of cells (Fig. 5).
These changes could be observed in both the periphery and the
center of the focus. As expected, in ischemic animals without
recirculation (Fig. 5, 0 hr), tra2-1 could be detected only in
nuclei, where it was localized in a speckled pattern. In contrast,
after 6 hr of recirculation, tra2-1 immunoreactivity could be
detected in the cytoplasma surrounding the nucleus (Fig. 5, 6 hr)
and the residual nuclear staining became more diffuse. Finally, 24
after MCA occlusion, most tra2-1 immunoreactivity disap-
peared from the nucleus and was located in the surrounding
cytosol (Fig. 5, 24 hr). At that time, tra2-1 could be detected
even in neurites emerging from the neurons. Staining with Neuro
Trace Nissl confirmed the integrity of the nuclei in cells showing
a cytosolic accumulation of tra2-1 (Fig. 5E).
We conclude that transient ischemia induces a hyperphospho-
rylation of tra2-1. This phosphorylation occurs several hours
after the ischemic insult and is accompanied by a translocation of
tra2-1 from the nucleus to the cytosol.
After ischemia, proteins interacting with tra2-1
translocate from the nucleus
Previous work shows that pre-mRNA processing occurs in a large
macromolecular complex in vivo (Corden and Patturajan, 1997;
McCracken et al., 1997), which has been named “transcriptosomal
complex” or “RNA factory.” Several studies have shown previ-
ously that tra2-1 interacts with components of this complex,
among them the SR proteins SRp75, SRp55, SRp40, SF2/ASF,
and splicing component 35 kDa (SC35) (Nayler et al., 1998a), the
hnRNP-like protein scaffold attachment factor B (Nayler et al.,
1998b), the SR protein kinases clk1–clk4 (Nayler et al., 1997), the
signal transduction and activation of RNA (STAR) protein SLM-
2/tra2-STAR (Venables et al., 1999), and hnRNP G-related pro-
tein (Venables et al., 2000). Several SR proteins shuttle continu-
ously between the nucleoplasma and the cytosol, which is
suggestive of cytosolic modification of the proteins as well as
additional roles of these proteins in nuclear export of mature
mRNA and in translation (Ca´ceres et al., 1998). In addition,
SAM68 was shown to leave the nucleus after viral infections
(McBride et al., 1996). We therefore determined whether tra2-
interacting proteins change their subcellular localization after
ischemia as well.
First, we used the mAb104 antibody that recognizes a phos-
phoepitope present in all members of the SR protein family
(Neugebauer et al., 1995). As shown in Figure 6A, mAb104
immunoreactivity translocates from the nucleus to the cytosol
similarly to tra2-1. However, this change in subcellular localiza-
tion occurs earlier than the one observed with tra2-1, because a
significant number of cells showed mAb104 immunoreactivity in
cytosol and neurites as early as 3 hr after reoxygenation.
We subsequently tested the ubiquitously expressed STAR pro-
Figure 2. Thapsigargin treatment changes alternative splicing patterns.
Primary cortical neurons were subjected to treatment with thapsigargin,
and the splicing pattern of the endogenous ICH-1S gene was determined.
C, Control receiving DMSO for 3 hr. D, Control receiving DMSO for 24
hr. Thapsigargin treatment times are indicated at the bottom of each
panel. A representative agarose gel of the RT-PCR products is on the lef t.
The drawing to the right shows schematically the primer localization and
the structure of the PCR products. The statistical evaluation of indepen-
dent experiments is shown the the bottom panel. Error bars indicate the
SD from at least four different experiments. Arrows indicate the location
of the primers used for PCR.
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tein family member SAM68 (Taylor et al., 1995; Vernet and
Artzt, 1997) and found that it also translocated from the nucleus
to the cytosol (Fig. 6B). Finally, we tested the related STAR
protein family member rSLM-2 (Di Fruscio et al., 1999; Stoss et
al., 2001). rSLM-2 regulates splice-site selection by binding to
purine-rich enhancers and was postulated to be a link between
signal-transduction pathways and pre-mRNA processing (Stoss et
al., 2001). We found that this protein remains in the nucleus of
cells in the ischemic focus, even 24 hr after reoxygenation (Fig.
6C). Furthermore, we could neither detect any DNA condensa-
tion in DAPI staining, nor did we observe any abnormal Nissl
staining (Fig. 5E). Together, these data indicated that ischemia
causes a translocation of some factors regulating pre-mRNA
splicing but does not affect the nuclear integrity.
Figure 4. tra2-1 is hyperphosphorylated after ischemia. Western blot
analysis of tissue derived from the ischemic focus ( I ) and from the
unaffected contralateral side that serves as a control (C) is shown. The
reoxygenation time is indicated at the top. The open arrow indicates the
hyperphosphorylated form, and the closed arrow points to the hypophos-
phorylated form. Molecular mass is indicated on the lef t.
Figure 3. tra2-1 immunoreactivity in an ischemic focus. Coronal mouse brain sections after 1 hr of transient focal cerebral ischemia and reperfusion
are shown. The columns correspond to 0, 3, 6, and 24 hr after recirculation. A, Determination of the regional ATP content in tissue sections. A luciferase
assay was used. Dark areas indicate normal ATP levels. ATP was depleted after 1 hr of ischemia (0 hr of recirculation), returned to normal levels at the
time of recirculation until 6 hr after ischemia, and developed secondary energy failure that was clearly visible at 24 hr after ischemia (asterisk). B, tra2-1
expression was determined in parallel sections by immunohistochemistry. Changes in the caudate–putamen were already detected at 6 hr and were clearly
evident 24 hr after ischemia. The area showing relocalization of tra2-1 is marked by a dotted line for the 24 hr time point. Cells from this area are
enlarged in Figure 5. C, DAPI staining of a parallel section shows the integrity of the nuclei. D, Quantification of tra2-1-positive cells in the ischemic
focus (blue) and in the unaffected cortex regions (red). con, Area of contralateral side corresponding to the ischemic focus; IF, area of ischemic focus;
con, cortical region of the contralateral side; IS, cortical region on the ischemic side.
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We then asked whether the changes we observed were caused
by cell death and tested the expression of cleaved caspase-3, a
marker for apoptosis. As shown in Figure 7, in the entire ischemic
focus, only a few cells could be detected expressing this marker,
which is in agreement with the data obtained in cell culture. In
contrast, tra2-1 and SR protein localization is strongly affected
in this area, because approximately one-half the nuclei are de-
pleted from tra2-1 (Fig. 3D). Furthermore, we did not observe
any abnormal Nissl staining (Fig. 5E). Our results indicate that the
observed change in subcellular localization is not caused by cell
Figure 5. tra2-1 protein changes its intra-
cellular localization after ischemia. The isch-
emic focus after 0, 3, 6, and 24 hr of recircu-
lation after the occlusion, stained with the
tra2-1 antiserum (A–D), is shown. The cells
were taken from the periphery of the isch-
emic focus. The lef t column shows an over-
view of the affected area at lower magnifica-
tion. On the right, representative cell nuclei
are enlarged to show the subcellular tra2-1
distribution. At the end of the 1 hr ischemic
interval (0 hr of recirculation), the speckled
pattern of tra2-1 is clearly visible. Twenty-
four hours after ischemia, the protein is re-
moved from the nucleus. Arrowheads in D
indicate protein that is present in neurites of
cells. E, Cells of the ischemic focus are coun-
terstained with Nissl stain (center) to demon-
strate the cytoplasmatic localization or
tra2-1 (overlay of Nissl and tra2-1 stain,
right). Nissl stain binds to RNA present in
the nucleus.
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death and the subsequent necrosis of the tissue. Similar results
were seen at all other time points and with terminal deoxynucleo-
tidyl transferase-mediated biotinylated UTP nick end labeling
(TUNEL) staining (data not shown).
We conclude that some but not all proteins interacting with
tra2-1 change their subcellular localization after transient ischemia.
The alternative splicing pattern of ICH-1 changes
after ischemia
SR proteins can change splice-site selection in a concentration-
dependent manner (Manley and Tacke, 1996). We investigated
Figure 6 continues.
Figure 6. Intracellular localization of tra2-1 interacting proteins after
ischemia. The lef t column shows an overview of the affected area at lower
magnification. The area analyzed is from the periphery of the ischemic
focus. On the right, representative cell nuclei are enlarged to show the
subcellular distribution. A, Detection of SR proteins with mAb104 in the
ischemic focus. The arrowheads in A (3h) show the staining in neurites. B,
Detection of SAM68 with anti-SAM68 antiserum in the ischemic focus. C,
Detection of rSLM-2 in the ischemic focus.
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whether the change in nuclear SR protein concentration is con-
comitant with a change in splice-site selection. We isolated tissue
from the ischemic area and from the contralateral control side
and performed RT-PCR. The ischemic focus was identified by the
lack of ATP in adjacent sections (Fig. 3). We tested the ICH-1
gene that can generate two isoforms, ICH-1L, which promotes
apoptosis, and ICH-1S, which prevents apoptosis (Wang et al.,
1994), which is observed as a late effect of ischemia (Dirnagl et
al., 1999). Again in agreement with the situation in culture, the
ischemic episode stimulates inclusion of the alternative exon,
which promotes the formation of the ICH-1S form (Fig. 8).
We conclude that concomitant with a decrease in nuclear
concentration of splicing factors, alternative splice-site selection
is changed in an ischemic focus.
DISCUSSION
Proteins regulating pre-mRNA processing change their
subcellular localization after ischemia
We demonstrated that splicing regulatory proteins changes their
intracellular localization in the brain after this tissue has been
subjected to ischemia. These findings are physiologically relevant,
because we relied on the analysis of endogenous proteins in cells
of intact tissue. Our results are in agreement with previous
studies that used overexpressed proteins in transformed cells that
were subjected to osmotic shock (van der Houven van Oordt et
al., 2000). We observed relocalization of tra2-1, SR proteins,
and SAM68 to the cytoplasma. Based on the morphology, the
cells where the translocation occurred were most likely neurons.
Several lines of evidence indicated that this relocalization was an
active process and not the result of a nonspecific breakdown of
the nuclear envelope. First, some factors, such as rSLM-2, were
not relocating to the cytosol; second, ribosomal RNA complexes
present in the nucleus did not change their localization; and third,
no evidence of apoptosis, either by cleaved caspase-3 or by
TUNEL staining, was observed. The most likely explanation of
our findings is that after ischemia, either the nuclear import
pathways were blocked or the nuclear export was increased. The
change in subcellular localization of tra2-1 was concomitant
with hyperphosphorylation. It remains to be established whether
this change in phosphorylation was the cause or the consequence
of a change in subcellular localization. Similar results were ob-
served when the influence of cellular stress, evoked by osmotic
shock, was studied on hnRNP A1 (van der Houven van Oordt et
al., 2000). Both tra2-1 and hnRNP A1 accumulate in the cytosol
after being hyperphosphorylated. Because both proteins bind to
transportin SR and transportin (Kataoka et al., 1999) (our un-
published data), a modulation of these systems by phosphoryla-
tion after ischemia is an interesting hypothesis that remains to be
tested.
The signal-transduction pathways leading to a change in splic-
ing factor phosphorylation are not clear. In contrast to cellular
events after osmotic shock (Kataoka et al., 1999; van der Houven
van Oordt et al., 2000), ischemia does not activate the MKK-p38
pathway in the brain.
Blockage of the calcium reuptake into the endoplasmatic retic-
ulum of primary neuronal cultures has effects similar to those of
ischemia. It is well established that the cytoplasmatic calcium
concentration increases after an ischemic insult, and in the cul-
ture system, we found relocalization of tra2-1 to the cytosol. It
is therefore likely that several independent pathways exist that
ultimately converge on the kinases that phosphorylate hnRNP A1
and tra2-1.
Splice-site selection is changed after ischemia
The current model of alternative splice-site selection assumes
that SR proteins and hnRNPs form a network across the pre-
mRNA that identifies exons (Wu and Maniatis, 1993; Manley and
Tacke, 1996; Hertel and Maniatis, 1998; Stoss et al., 2000; Hast-
Figure 6 continued.
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ings and Krainer, 2001), which is reflected by their ability to
regulate splice-site usage in a concentration-dependent manner
(Ca´ceres et al., 1994; Wang and Manley, 1995). The effect of SR
protein kinases on splice-site selection has been attributed to a
recruitment of SR proteins from their nuclear storage sites, the
speckles, and a subsequent increase in nuclear SR protein con-
centration (Stojdl and Bell, 1999; Misteli, 2000). Because the
relocation of tra2-1 and SR proteins to the cytosol will decrease
its concentration relative to other factors regulating splice-site
selection, we tested the ICH-1 pre-mRNAs that undergo alterna-
tive splicing in the brain.
We observed an increase in inclusion of the 61 bp alternative
exon of ICH-1. An increase in the SR protein SC35 and SF2/ASF
concentration was shown to promote skipping of the 61 bp alter-
native exon of ICH-1 (Jiang et al., 1998). Therefore, the increase
in usage of this exon after ischemia could be explained by the
relocation of SR proteins from the nucleus to the cytosol. The
effects on RNA splicing seem to be specific, because the splicing
patterns of several mRNAs were not changed. For example,
alternative splicing patterns of Bax, Bcl, and SERCA2 genes were
not affected. Furthermore, we did not observe an increase in
RNA degradation (data not shown). The twofold to threefold
changes in exon usage were comparable with the effects seen in
other systems that have investigated endogenous mRNAs (Kaufer
et al., 1998; Daoud et al., 1999; Xie and Black, 2001). Changes of
this magnitude are physiologically relevant; for example, a 1.8-
fold increase in prothrombin pre-mRNA can cause human dis-
ease (Gehring et al., 2001). In several systems studied (e.g.,
drug-induced increase in neuronal activity and stress evoked by
forced swimming) (Kaufer et al., 1998; Daoud et al., 1999), a
change in alternative splice-site selection was found as a molec-
ular mechanism to memorize an external stimulus. Because
tra2-1 acts on several pre-mRNAs containing purine-rich en-
hancers (P. Stoilov, R. Daoud, O. Nayler, and S. Stamm, unpub-
lished observations), it is likely that the translocation of tra2-1 in
cells affected by ischemia will orchestrate a coordinate change in
alternative splice-site selection of several genes that will add to
the long-term effect observed after ischemia.
We conclude that cells are able to increase the concentration of
splicing regulatory proteins by recruiting them from nuclear stor-
age sites and are able to decrease their concentration in the
nucleus by transporting them to the cytosol. Because splice-site
selection is dependent on the relative concentration of splicing
regulatory proteins, pre-mRNA splicing patterns of some genes
are changed as a result.
Regulation of splice-site selection by subcellular
localization of regulatory proteins
To our knowledge, this is the first report demonstrating a change
in subcellular localization of endogenous proteins regulating
splice-site selection in intact tissue. To determine possible molec-
ular mechanisms, we investigated whether a change in the intra-
Figure 7. The apoptotic marker cleaved caspase-3 is present
in only a few cells in the ischemic focus. A, DAPI staining of
a coronal section, including the ischemic focus (i.e., the left
caudate putamen). The section shown is from an animal
subjected to 1 hr of focal cerebral ischemia and then 6 hr of
recirculation. B, Immunostaining of a parallel section with an
antiserum recognizing the cleaved caspase-3 product. The
box shows the area that is enlarged in C. C, Enlargement of
the area marked in B. Cells expressing cleaved caspase-3 are
indicated with arrowheads.
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cellular calcium concentration had an effect that is comparable
with ischemia. We blocked intracellular calcium reuptake and
observed a change in the subcellular distribution of regulatory
proteins in cultured cortical neurons. Interestingly, alternative
splicing patterns of the ICH-1 gene parallel the situation in the
ischemic brain. This suggests that the calcium concentration
could be part of the cascade connecting ischemia to changes in
pre-mRNA splicing.
There is now increasing evidence that external stimuli can
regulate pre-mRNA processing. Some of these stimuli are within
the physiological range. For example, stress induced by forced
swimming in mice increases the intercellular calcium concentra-
tions and changes the alternative splicing patterns of the acetyl-
choline esterase gene (Kaufer et al., 1998; Grisaru et al., 1999).
Other nonphysiological stimuli (e.g., neuronal activity in models
of epilepsy) (Vezzani et al., 1995; Daoud et al., 1999), potassium
stimulation of cultured cells (Xie and Black, 2001), and osmotic
(van der Houven van Oordt et al., 2000) and temperature shock
(Takechi et al., 1994; Bournay et al., 1996; Ars et al., 2000) can
also result in a change in alternative splicing pathways. However,
the signal-transduction pathways that mediate these changes are
just beginning to emerge. The effects of potassium stimulation are
mediated by calcium/calmodulin-dependent protein kinase IV
(Xie and Black, 2001), which also suggests a role of intracellular
calcium in splice-site regulation.
Phosphorylation was shown to release splicing factors from
their internuclear storage sites, the speckles (Misteli, 2000), but
under these experimental conditions, no accumulation of splicing
factors in the cytosol was observed. We suggest that accumulation
of splicing factors in the cytosol is a second mechanism to regu-
late the internuclear concentration of those proteins, which in
turn can affect splice-site selection. It is likely that in most
physiological stimulations, the change in subcellular localization
will not be as dramatic as in ischemia, where nuclei are depleted
from some splicing factors. Furthermore, it is possible that these
proteins fulfill roles in the cytosol that need to be determined.
Because 47–60% of all human genes are alternatively spliced
(Lander et al., 2001; Modrek et al., 2001), regulation of splice-site
selection is emerging as an important mechanism to regulate gene
expression. In the future, DNA chip analysis will show what
subset of exons is regulated by the decrease in nuclear tra2-1
concentration and the identification of splicing-related signal-
transduction pathways will offer the opportunity for drug design
in ischemia.
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